newsletter is out, page-25

When I first met Harry almost 2 years ago now, one of the things he stated in the meeting was “read our announcements carefully, its all in the announcements, but you must read them closely to pick up what most miss”
 
Two separate projects have been highlighted today
 
Mastitis
 
“Successful studies will result in significant revenues for the company as this market will require the manufacture and sale of substantial amounts of TPM® product to meet anticipated future demand.”
 
 
Manufacturing
 
We continue to develop commercial opportunities in animal health and human supplements as this does not impact our oxycodone technical development, the prime focus of the company. Potential TPM® demand for commercial products may require an increase in manufacturing capacity.
 
 
The change in the two paragraphs here is that the animal health referred to in the manufacturing  paragraph is entirely different to the mastitis paragraph
 
So clearly they are working in animal and human health supplements with as well as mastitis products
 
Animal health supplements are a big market as was covered in TL’s Animal Crackers thread from Feb this year